Statistics

Total Visits

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).18

Select a period of time:

Number of views in the range

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).11

Views

Views
March 20241
April 20240
May 20243
June 20242
July 20242
August 20240
September 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Spain1
 

Top cities views

Views
Chicago3
Prineville1
Seville1